Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to learn more about Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders. Data is being collected on three types of NBIA disorders:

Pantothenate Kinase-Associated Neurodegeneration (PKAN), PLA2G6-associated Neurodegeneration (PLAN) and Beta-propeller Protein-associated Neurodegeneration (BPAN). The study will (1) collect information about how symptoms and findings in NBIA change over time and (2) identify measures of NBIA that can be used in future clinical trials. Participants will follow links to a secure website every 6 months for a period of 5-10 years to electronically complete a set of rating scales as related to their NBIA disorder.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Nerve Degeneration
  • Neurodegeneration With Brain Iron Accumulation (NBIA)
  • Pantothenate Kinase-Associated Neurodegeneration

NCT number NCT02587858
Study type Observational
Source Oregon Health and Science University
Contact Alison C Freed, BA
Phone 503 494 6838
Email freeal@ohsu.edu
Status Recruiting
Phase
Start date April 2015
Completion date April 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05522374 - TIRCON International NBIA Registry
Completed NCT05615571 - Testing of NBIA Genes: Analysis of Genetic Heterogeneity and Validation of Mitochondrial Markers for Assessing Causality of Sequence Variants.
Recruiting NCT05696912 - Functional Tests to Resolve Unsolved Rare Diseases. Rares. N/A